.

Previous Requests - January 2017

Date Reference

Question(s)

Response 
02/01/2017 468/17

1. In the period of financial year to date:

a. How many individual funding requests for the usage of Infliximab in the treatment of  Hidradentis Suppurativa has the CCG received?
b. Of the above, is it possible to say how may have been approved?

2. Are there any gainshare agreements in place between the CCG and a provider (eg. hospital trust)?

If “Yes”, then please provide the following details:

  • Disease area
  • Provider included in the gainshare agreement
  • Names of any specific drugs involved
  • What savings have been made (approximate amount)?                                

3.  Have any gainshare agreements been terminated, and if so which disease areas?

Click here for Response      
04/01/2017 469/17

Please provide me with a list of all GP networks, federations, super practices and new primary care models operating within NHS Southern Derbyshire CCG:

For each group please include:

  • Group name
  • What category they fall under - either network, federation, super practice or new care model. If new care model please include what type of model i.e. Multi-speciality community provider, Primary Care Home, Primary and Acute care collaboration
  • Number of practices which are members
  • Registered patient list size
  • Name and job title of accountable figure, or leader(s) of the group
  • Type of legal entity
  • Number of staff employed by the group
Click here for Response
03/01/2017 470/17

I am writing to you under the Freedom of Information Act 2000 to request the following information from all departments of Southern Derbyshire Clinical Commissioning Group including Safeguarding.

1. A copy of all correspondence, communications and information supplied to CQC prior to their visit to Lister House Surgery and Lister House Chellaston in 2016.

Click here for Response

Please contact us for attachments

            
04/01/2017 471/17

A list of all services or pathways decommissioned or altered – and the details of their alteration – for the 2017-2019 contracting period as required by the NHS England deadline of December 23. Please categorise each with the acute/community setting where they are, or will take place (ie. Queen’s Medical Centre, Nottingham). And please provide the former and new value of the service. If the final details haven’t been ratified please provide latest proposal and the status of that plan.

Click here for Response
04/01/2017 472/17

Please provide the General Practice Forward View Plan(s) submitted by your CCG(s) to NHS England as required in the NHS Operational Planning and Contracting Guidance 2017-2019 by 23 December 2016.

Click here for Response
04/01/2017 473/17

1. The amount spent on NHS-funded nursing care in care homes each financial year from 2013-14 to 2015-16 by NHS Southern Derbyshire CCG.              

2. The estimated amount that NHS Southern Derbyshire CCG will spend on NHS-funded nursing care in care homes in 2016-17 based on the 40 per cent increase announced by the Department of Health.

3. The number of patients receiving NHS-funded nursing care in care homes each financial year from 2013-14 to 2016-17.

Click here for Response

Click here for Attachment

06/01/2017 474/17

1. Who provides the organisations BACS payments and Direct Debit collection software?

2. Please provide a list of your suppliers of the above software.

3. How you came to the decision to choose these companies?

4. Are these solution(s) hosted on premise or cloud hosted?

5. Please provide expenditure on computer software used for Bacs payment processing and Direct Debit collection, for financial years 2014/2015 and 2015/2016.

6. When does your current contract(s) with BACs payment and direct debit collection software expire?

7. Will this service(s) be tendered and if so where?

8. What is the total value of your current BACS payment and Direct Debit collection software contract(s) and over what period?

9. With whom does the organisation hold its primary bank account?

10. Does the organisation, acting as a Bureau, provide Bacs processing on behalf on any other organisation?

11. What payments types does the organisation use? (eg. Bacs (Direct Credit), Direct Debit, Faster Payments, etc.).

12. Who is the person responsible for BACS processing and Direct Debit collection software?

  • ­Name
  • ­Position
  • ­Telephone Number
  • ­Email
Click here for Response
06/01/2017 475/17

1. In relation to the current financial year (16/17) could you please provide me with information relating to the first ten occasions in which you sanctioned the use of a patient’s Personal Health Budget (PHB) to be spent on something that was NOT for the provision of care, medicine, or transport to a place where care or medicine was provided.

2. For each of these ten occasions please state (i) what the money was spent on and (ii) how much money was spent on it and (iii) what was the outcome the patient was working towards as a result of this spend?

Click here for Response
09/01/2017 476/17

1. Is the STP another reorganisation of health services? Does it replace current structures in Derby and Derbyshire?

2. When will the SDCCG cease to exist?

3. What stage has been reached in deciding on the staffing structure, job descriptions, interviews etc.?

4. Are there plans to move out of Cardinal Square to a more central location in mid Derbyshire?

5. When will the list of dates & venues for the LONG promised meetings of Chief Officers with the people of Derbyshire to explain their plans for our health services be published?

Click here for Response
09/01/2017 477/17

1.    What are the various remuneration packages & expenses paid to members of the SDCCG Governing Body, excluding the salaried Officers?

2.    Assuming there is a range of amounts, perhaps you could classify them by status, expertise, attendance expected, etc. to give some clarity.

Click here for Response
09/01/2017 478/17

1. How many referrals, (under CHC Data) exceeded 28 days referral time in quarter 1for 2016/17?

2. How many referrals, (under CHC Data) exceeded 28 days referral time in quarter 2 for 2016/17?

Click here for Response
09/01/2017 479/17

1. How many referrals, (under CHC Data) exceeded 28 days referral time in quarter 1for 2016/17?

2. How many referrals, (under CHC Data) exceeded 28 days referral time in quarter 2 for 2016/17?

Click here for Response
10/01/2017 480/17

1. Patient numbers provided with Home Oxygen as of March 2015, March 2016 and the latest data you have available.

2. Of your latest patient data, how many patients have:

i. Liquid oxygen (LOX)
ii. Portable Oxygen Concentrator (POC)
iii. Transportable Oxygen Concentrator (TOC)
iv. Home Fill / Self Fill Concentrator

3. Please provide total annual spend on the Home Oxygen Service for your CCG excluding VAT and electricity for the period April 2015 – March 2016.

4. Please provide copies of the minutes of Regional Service Review Meetings with your Home Oxygen Service provider since April 2014      

5. Please provide the details of the objective, scope and findings of any clinical audits that have been taken on the Home Oxygen Service in the past three years for your CCG.

6. Please provide the supplier's monthly KPI performance from January 2015 – January 2017 inclusive for your CCG.

7. Please provide data on your CCGs arrangements for Home Oxygen Service Assessment and Review.

8. Please provide details of all complaints and serious incidents (SIRI) relating to the Home Oxygen Service received by your current HOS supplier for your CCG from January 2016- December 2016

Click here for Response
11/01/2017 481/17

The attached excel spreadsheet contains a list of questions to be answered under the FOIA. Please provide all of this information in excel format by completing and returning this spreadsheet. Please do not send the organisations response in pdf.

Click here for Response

Click here for Attachment

13/01/2017 482/17

The breakdown of patients on Oral Nutritional Supplements referred to a dietitian.

Click here for Response
14/01/2017 483/17

1. How many People received full CHC funding for 2015/2016?

2. Of these split by county:

a. How many of these were in Residential Care homes, Nursing Care Homes, Hospitals, how many were in their own homes?
b. How many continued to receive CHC funding following first review?

Click here for Response
16/01/2017 484/17

1. Are GP Out of Hours (OOH) Services within the footprint of your organisation commissioned and contracted centrally by NHS Southern Derbyshire CCG or are the provision and contracting of these services up to the individual GP practices?

2. If the OOH services are commissioned and contracted by NHS Southern Derbyshire CCG, who is the current provider of GP OOH services? (Please provide name)

3. How long is the current contract with this provider?

4. Over the past calendar year (Dec 2015 to Dec 2016), how much was spent by NHS Southern Derbyshire CCG on GP OOH Services?

5. If some of your GP practices commission their own GP OOH services, which ones are currently doing this?  (please identify, if possible, by Organisation Code)

Click here for Response
17/01/2017 485/17

1. What is the name of the responsible officer (s) for the management of ambulance and transport services?

2. What is the name of the responsible procurement officer (s) for ambulance and transport services?

3. Did you use a procurement service or Commissioning Support Unit to commission the services?
a. If so, which one?

4. What is the geographical area of responsibility for your Trust or CCG?

5. Who is your current provider of Non-Emergency Patient Transport Services?

6. When did the current contract for Non-Emergency Patient Transport Services begin?

7. What is the contracted duration of the Non-Emergency Patient Transport Services contract, including the potential for extensions?

8. Have any contract extensions been used?

9. What is the annual value of the contract?

10. When is the scheduled date for the contract re-tender OJEU notice to be published?

11. When is the scheduled date for the re-tender procurement exercise to be begin

12. When is the scheduled date for the award of re-tendered contract?

13. When is the scheduled date for the retendered contract to be awarded?

14. How many patient journeys were contracted under the NEPTS contract between 1 January 2015 to 31 December 2015?

15. What was the value of these journeys?

16. Is the contract in partnership with any other CCG or NHS Trust?

17. How is your current contract constructed? Pay per journey, fixed price or other?

18. Who currently provides your extra contractual journeys?

19. What constitutes an extra contractual journey? E.g. what are the boundary parameters? 10 miles outside the CCG area?

20. What is the value of the Extra Contractual Journeys for the period 01 January 2015 to 31 December 2015?

21. What volume and percentage of your patients travel from the following mileage bands?
a. Within 5 miles: xxx Journeys, xxx %
b. Within 6 - 10 miles: xxx Journeys, xxx %
c. Greater than 10 miles: xxx Journeys, xxx % 

22. Please confirm what categories of journeys are included in the contract?

  • Admission
  • Outpatient
  • Discharge
  • Transfer
  • Home Visit
  • Day Patient
  • Renal
  • Wait & Return
  • Inter Facility Transfers
  • High Dependency Transfers
  • Mental Health Transfers

23. What types of journeys, if any are excluded from your current contract?

24. Does your NEPTS provider cover any other service for the Trust;

  • Courier Services
  • Shuttlebus Services
  • Staff Taxis
  • Eligibility & Assessment / Call Centre
  • Mental Health / Secure transfers
  • Renal Services
  • Post / Medical Records
  • Portering Services
  • Dedicated Paediatric or specialist Transfer Services

25. What performance metrics are used to assess performance on the contract?

26. How does the current contract incentivize good performance?

27. How does your current contract penalize poor performance?

Click here for Response
16/01/2017 486/17

1. The annual budget for Palliative Care Unit at Royal Derby Hospital

2. Annual PBR income for the service.

3. An outline of the model and cost of commissioning Community Specialist Palliative Care Nursing Services in southern Derbyshire.

Click here for Response

Click here for Attachment1

Click here for Attachment2

17/01/2017 487/17

1. A full list of NHS services and locations supplying emergency care telephony call handling or any NHS service that handles such call, such as 999 call centres for your area.

2. A full list of non-NHS or companies supplying (and their locations) non-emergency care call handling services, such as 111 or GP out of hours.

Click here for Response
18/01/2017 488/17

1. How much did the CCG spend on vascular services in the following fiscal years: 2014-2015, 2015-2016?

2. How much did the CCG plan to spend on vascular services in the fiscal year 2016-2017?

3. Does the CCG follow any best practice pathways for treating patients with suspected or confirmed vascular disease – including Peripheral Arterial Disease and Critical Limb Ischaemia? If so, please provide details of this.

4. Does the CCG have a named contact person for vascular disease in:

a. Hospital setting and/or;
b. Community setting, 24 hours a day who is a member of the multidisciplinary team in case of emergencies?

5. Does the CCG carry out workforce planning to support your vascular services? If so, please provide details. 

Click here for Response

Click here for Leg Ulcer Pathway

19/01/2017 491/17

I am trying to find out whether there has been an increase in babies aged 0-12 months being diagnosed with eczema over the last 5 years. Specifically in the years 2012, 2013, 2014, 2015 and 2016. 

Please send me any information you have, whether it is local data of if you have anything on a national scale.

Click here for Response           
20/01/2017 492/17

1. Does the CCG provide any financial incentives to GP surgeries for reducing the number of inappropriate referrals for hospital treatment and/or diagnostic tests? (yes or no)

If yes, please answer the following:

2. Please briefly detail how the incentive works, including:

a. What the incentive is - please state maximum value awarded and any conditions.
b. What reductions or targets GPs must achieve in order to receive this incentive.
c. How the incentive is awarded/who receives it, e.g. is it paid directly to practices? 

3. Are there any specific specialities, procedures or treatments that this incentive applies to? Or if easier, specify where it does not apply.

4. How much did the CCG pay to GP practices under the incentive scheme in:

a. 2015/16
b. 2016/17 to date 

5. Does the CCG provide any non-financial incentives to GPs for reducing the number of inappropriate referrals for hospital treatment and/or diagnostic tests? If yes, please give details as to what the incentive is, how it is awarded and what specialities it applies to.

Click here for Response
20/01/2017 493/17

Please disclose under the Freedom of Information Act the following for adult and/or children’s hospice services in your area - please be clear whether you’re referring to adult or children’s services:

1. Your funding arrangements with local hospices ie grant/contract specific services

2. Details of any contract arrangement if applicable

3. How many hospices you fund

4. The total sum given to each hospice in your area for the financial years 2015/16, 2014/15, 2013/14, 2012/13, 2011/12 and 2010/11

5. Your budget (or proposed budget if not yet finalised) for hospice funding for 2016/17

6. If available, how many patients in your area received end-of-life care from a charitable hospice in the financial years 2015/16 and 2010/11. Please give a breakdown with number of adults and children.

Click here for Response

Service Specification 1

Service Specification 2

20/01/2017 494/17

The caseload across your primary care dietetic team for the last full year.

Click here for Response
23/01/2017 495/17

Please provide me with the following information relating to staffing within the pharmacy department (all areas including: dispensary, clinical, aseptics, clinical trials, MI).

1. How many permanent staff are employed by the pharmacy department?

2. How many permanent vacancies are currently open/unfilled within the pharmacy department?

3. How many agency staff/locums are currently being used across the pharmacy department?

4. How many bank temps are being used across the pharmacy department?

5. During the 2015-2016 financial year, how much did the pharmacy department spend on temporary agency staff?

6. During the 2015-2016 financial year, how much did the pharmacy department spend on temporary bank staff?

7. During the 2015-2016 financial year, how much did the pharmacy department spend on permanent finders/introduction fees through recruitment agencies?

8. Does the pharmacy department utilise frameworks for temporary staffing?  If so, which framework is of choice?

9. Does the pharmacy department book agency staff direct with agencies or do all bookings run through a centralised temporary staffing team?

10. Does the pharmacy department work within a master vendor agreement or managed service agreement?

11. Which agencies does the pharmacy department use for temporary/locum staff?

12.  Please provide me with the following contact names within the authority:
a. The name of the senior manager (Chief Pharmacist/Director of Pharmacy) with overall responsibility for the pharmacy department.
b. The name of the head of temporary staffing.

Click here for Response
23/01/2017 496/17

We request information in relation to all the medicines listed below which are marketed for the treatment of chronic obstructive pulmonary disease:

a. Anoro (vilanterol and umeclidinium) which is marketed by GlaxoSmithKline
b. Braltus (tiotropium) which is marketed by Teva
c. Duaklir (aclidinium bromide and formoterol fumarate dihydrate) which is marketed by Astra Zeneca
d. Eklira (aclidinium) which is marketed by Astra Zeneca
e. Incruse (umeclidinium) which is marketed by GlaxoSmithKline
f. Seebri (glycopyrronium) which is marketed by Novartis
g. Spiolto (tiotropium and olodaterol) which is marketed by Boehringer Ingelheim
h. Spiriva (tiotropium) which is marketed by Boehringer Ingelheim
i. Ultibro (indacaterol and glycopyrronium) which is marketed by Novartis or Pfizer
(the “COPD Medicines”).

In respect of each of the COPD Medicines, please could you provide us with the following information:

1. A copy of any agreement relating to a rebate, discount, patient access, risk-sharing or other pricing scheme entered into by Southern Derbyshire CCG in relation to the COPD Medicines which results in Southern Derbyshire CCG paying less than the NHS list price for such COPD Medicines (whether by way of discount, rebate etc.)

2. A copy of any communications between Southern Derbyshire CCG and the company or companies marketing such COPD Medicine in relation to such scheme.

3. Any information or requests sent to GP practices comprised within the CCG in the 6 months since contract signature with respect to such COPD Medicines schemes.

Click here for Response
24/01/2017 497/17

1. A list of locally commissioned enhanced services in your area.

2. The contract specification for each of these (either as an attachment or weblink where appropriate).

3. The associated funding (if not stated in the specification).

Click here for Response

Please contact us to obtain copies of attachments          

25/01/2017 498/17

1. Please state whether the following five paediatric continence services have been commissioned by your CCG:

a. Bedwetting
b. Daytime wetting
c. Toilet training
d. Constipation/soiling
e. Product supply for paediatric continence problems 

If any of the above services are not commissioned by your CCG, please let us know which partner organisation does commission the service.

2. Is there a single service for the above five problems?  If the answer is yes, is this service led by a paediatric continence advisor?

3. If the answer to question 2 is no, please list the services that are commissioned to handle these problems and the designation of each of the service leads.

4. For each of the above five services, please state how many people aged from birth to 18 years were referred to the service in each of the last five years.

5. Do you have any future plans to:

a. Commission a new paediatric continence service?
b. Review the existing paediatric continence service?

If so, please provide details.

6. How many nurses specialising in paediatric continence are currently employed by the services commissioned by your CCG? Please specify whether they have had specific training in:

a. Children’s nursing
b. Paediatric continence management.

7. Are you aware of the NICE-accredited Paediatric Continence Commissioning Guide? If so, do the services commissioned in your CCG use it?

Click here for Response
26/01/2017 499/17

1. A list of all blood glucose test strip rebate schemes that  were previously in place in Southern Derbyshire CCG and have since come to an end.

2. A list of all blood glucose test strip rebate schemes that are currently in place in Southern Derbyshire CCG.

3. For each of the blood glucose test strip rebate schemes currently in place in Southern Derbyshire CCG, please provide the following information where possible:

  • The name of the blood glucose test strip included in the rebate scheme.
  • The start and, if applicable, end date of the rebate scheme.
  • Is the rebate scheme based on an agreed volume?
  • Is the rebate scheme based on a percentage of blood glucose test strips prescribed?
  • Is there any other condition to the rebate scheme?
  • What is the value of the discount applied to the NHS Drug Tariff price of the blood glucose test strip?

4. What is the total income for Southern Derbyshire CCG from blood glucose test strip rebate schemes for the years 2015 and 2016?

Click here for Response
26/01/2017 500/17

1. Please supply the name, email address and telephone number of the commissioner with responsibility for inpatient mental health rehabilitation services.

For questions 2 through 6, please supply the following information as a snapshot at the end of the year for the financial years 2013/14 to 2015/16, and where possible, the most up to date snapshot available for 2016/17.

2. Please provide the total number of adults funded by the CCG in inpatient mental health rehabilitation services.

3. Of the total number of adults funded by the CCG in inpatient mental health rehabilitation services (Q2) please provide the number that are:

a. Male
b. Female

4. Of the total number of adults funded by the CCG in inpatient mental health rehabilitation services (Q2) please provide the number that were:

a. Placed ‘in area’
b. Placed ‘out of area’

5. Of the total number of adults funded by the CCG in inpatient mental health rehabilitation services (Q2) please provide the number that were placed in:

a. NHS hospital units
b. Independent provider hospital units

6. Of the total number of adults funded by the CCG in inpatient mental health rehabilitation services (Q2) please provide the number that were placed in:

a. Locked rehabilitation units
b. Open rehabilitation units

7. What is the average length of stay in adult inpatient mental health rehabilitation services?

8. What is the highest and lowest recorded daily/weekly (please specify which value is included in your response) fee for an adult inpatient mental health rehabilitation service placement?

9. Please provide the total expenditure on adult mental health inpatient mental health rehabilitation service placements for each of the financial years 2013/14 to 2015/16, and where possible, budgeted expenditure for 2016/17.

10. Please provide a list of providers (both NHS and private hospitals) that received this funding (Q9).

Click here for Response

Click here for Attachment

27/01/2017 501/17

Can you update the attached spreadsheet where we ask about general IT infrastructure and cyber security information please?

Click here for Response

Click here for Attachment

31/01/2017 502/17

1. Please state what percentage of CCG staff have received training on the government's Prevent strategy and the statutory duty to report those at risk of being drawn into terrorism.

2. Please state whether staff have received any further training on the Prevent Strategy apart from the Workshop to Raise Awareness of Prevent (WRAP training). If yes, please state what further training they receive

3. Please state whether all staff receive training on the Prevent Strategy or just clinical staff

4. Please state the number of people who the CCG has referred to Prevent since the duty was introduced in 2015. Please state how many of these people have been referred to the Channel programme.

5. Please state what proportion of referrals (if you have made any) have involved patients and what proportion have involved staff.

Click here for Response
Last modified: 28/02/2017